Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis.
Saved in:
| Title: | Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis. |
|---|---|
| Authors: | Muthukrishnan VY; CSL Behring LLC, King of Prussia, Pennsylvania, USA., Kerbusch T; Certara USA, Inc., Radnor, Pennsylvania, USA., Strong LE; Certara USA, Inc., Radnor, Pennsylvania, USA., Kleijn HJ; Certara USA, Inc., Radnor, Pennsylvania, USA., Pfister M; Certara USA, Inc., Radnor, Pennsylvania, USA., Chang AM; CSL Behring LLC, King of Prussia, Pennsylvania, USA., Acharya M; CSL Behring LLC, King of Prussia, Pennsylvania, USA., Nandy P; CSL Behring LLC, King of Prussia, Pennsylvania, USA., McCune JS; CSL Behring LLC, King of Prussia, Pennsylvania, USA. |
| Source: | Clinical and translational science [Clin Transl Sci] 2025 Nov; Vol. 18 (11), pp. e70381. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1752-8062 |
|---|---|
| DOI: | 10.1111/cts.70381 |
